ANDROVICOVA, R., J. HORACEK, Tibor ŠTARK, F. DRAGO and Vincenzo MICALE. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? PHARMACOLOGICAL RESEARCH. London: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2017, vol. 115, JAN 2017, p. 200-208. ISSN 1043-6618. Available from: https://dx.doi.org/10.1016/j.phrs.2016.11.021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
Authors ANDROVICOVA, R. (203 Czech Republic), J. HORACEK (203 Czech Republic), Tibor ŠTARK (703 Slovakia, guarantor, belonging to the institution), F. DRAGO (380 Italy) and Vincenzo MICALE (380 Italy, belonging to the institution).
Edition PHARMACOLOGICAL RESEARCH, London, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2017, 1043-6618.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.897
RIV identification code RIV/00216224:14110/17:00097677
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.phrs.2016.11.021
UT WoS 000392790400018
Keywords in English Endocannabinoids; Delta(9)-THC; Cannabinoid CB1 receptor; Sexual behavior
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 16:34.
Abstract
The endocannabinoid system (ECS), which is composed of the cannabinoid receptors types 1 and 2 (CB1 and CB2) for marijuana's psychoactive ingredient Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the endogenous ligands (AEA and 2-AG) and the enzymatic systems involved in their biosynthesis and degradation, recently emerged as important modulator of emotional and non-emotional behaviors. For centuries, in addition to its recreational actions, several contradictory claims regarding the effects of Cannabis use in sexual functioning and behavior (e.g. aphrodisiac vs anti-aphrodisiac) of both sexes have been accumulated. The identification of Delta(9)-THC and later on, the discovery of the ECS have opened a potential therapeutic target for sexual dysfunctions, given the partial efficacy of current pharmacological treatment. In agreement with the bidirectional modulation induced by cannabinoids on several behavioral responses, the endogenous cannabinoid AEA elicited biphasic effects on sexual behavior as well. The present article reviews current available knowledge on herbal, synthetic and endogenous cannabinoids with respect to the modulation of several aspects of sexuality in preclinical and human studies, highlighting their therapeutic potential. (C) 2016 Elsevier Ltd. All rights reserved.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1284/2015, interní kód MUName: Experimentální farmakologický vývoj v neuropsychiatrii a onkologii
Investor: Masaryk University, Category A
PrintDisplayed: 25/7/2024 21:46